GlassScriptPhysician profile
Christopher Michael Stewart
NPI 1619402294
$5,484.28
in general payments reported to CMS, 2019-2025
17 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $585 · 2021: $1,803 · 2022: $393 · 2023: $1,141 · 2024: $1,413 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,695 · Travel and Lodging: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.20 |
| Travel and Lodging | $1,007.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,863.18 | 2020-2022 | |
| Acumed LLC | $1,117.99 | 2024 | Acumed, Innate Implant, Inframe Implant |
| Trimed, INC. | $433.25 | 2023 | |
| Bard Peripheral Vascular, INC. | $380.68 | 2021 | |
| Checkpoint Surgical, INC | $273.71 | 2023-2024 | Checkpoint Stimulators |
| Abbvie INC. | $236.55 | 2023 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Depuy Synthes Sales INC. | $207.67 | 2020-2023 | Trumatch, Matrixorthognathic |
| Axogen | $183.19 | 2021-2023 | Avance Nerve Graft |
| Davol INC. | $153.37 | 2022 | |
| Baxter Healthcare | $140.83 | 2020-2021 | |
| Medical Device Business Services, INC. | $124.32 | 2025 | Dermabond |
| Mentor Worldwide LLC | $122.62 | 2021 | |
| Kerecis Limited | $94.76 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ossur Americas, INC. | $57.00 | 2024 | I-Digits Quantum |
| Rti Surgical, INC | $39.38 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $30.95 | 2020 | |
| Heron Therapeutics, INC. | $24.83 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.